Psychedelic-assisted psychotherapy has now been legalised in Australia; however, the therapeutic mechanisms underlying these treatments remain insufficiently defined within existing psychotherapy models. Are the changes observed following psychedelic use driven solely by psychopharmacological effects, or do psychedelic states create a unique therapeutic window that deepens, accelerates, or amplifies psychotherapeutic processes? How might mechanisms such as neuroplasticity, enhanced interoceptive awareness, and shifts in consciousness relate to phenomena therapists typically conceptualise as dissociation, trauma processing, or memory integration?

This webinar will trace the historical use of psychedelics in human cultures, review contemporary research on mechanisms of action, and position these insights within relational psychotherapy and trauma treatment. Participants will be invited to reflect on how psychedelic-assisted therapy may interface with core therapeutic processes and where future research and clinical innovation could be directed.

Learning Outcomes

By the end of this webinar, participants will be able to:

• Describe key historical, neuroscientific, and psychotherapeutic perspectives on psychedelic-assisted treatment and its proposed mechanisms of action.
• Analyse how psychedelic-induced states—including heightened neuroplasticity, altered interoception, and shifts in consciousness—may interact with core relational and trauma-focused therapeutic processes.
• Evaluate emerging clinical questions and potential directions for future research within psychedelic-assisted psychotherapy, particularly as they relate to trauma, dissociation, and relational models of care.

Venue: Live Webinar  (Zoom registration required. Please check your booking confirmation email).

Date: Wednesday, 10th June, 2026 

Time: 6.30 p.m. to 8.00 p.m. (Sydney/Melbourne/Canberra Time)

Cost: Free (Live Webinar Only)

A$14.99 (Live Webinar &/or Access to Recording for 60 days)

CPD Certificate: 1.5 Hours. CPD certificates are issued to attendees who meet one of the following criteria: attend the live webinar with at least 80% attendance, or watch the webinar recording and complete the associated assessment component.

 About Dr Jamie Rickord: Dr Jamie Rickord is a GP, psychoanalytic psychotherapist and one of Australia’s most experienced prescribers and educators of cannabinoid medicine. His primary interest is the development and integration of effective therapeutic interventions that include mindbody medicine, psychotherapy and the considered use of novel pharmacological adjuncts to assist therapists in the treatment of trauma.

About eiseEducation: eiseEducation is a global leader in professional development for psychotherapists and mental health practitioners. We offer expert-led webinars, short courses, and training programs designed to deepen clinical skills and support evidence-based practice. With roots in Australia and New Zealand and an expanding global audience, eiseEducation is committed to empowering those who support mental health and emotional well-being around the world. Discover more at eiseeducation.com

Contact Event Organiser